NIRS in moyamoya syndrome

  • Research type

    Research Study

  • Full title

    Near infrared spectroscopic assessment of paediatric Moyamoya syndrome.

  • IRAS ID

    212831

  • Contact name

    Martin Tisdall

  • Contact email

    martin.tisdall@gosh.nhs.uk

  • Sponsor organisation

    Great Ormond Street Hospital NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 11 months, 30 days

  • Research summary

    Near infrared spectroscopy (NIRS) is an established technique that allows non-invasive measurements oxygen levels and blood flow within the brain. It is therefore an ideal way to monitor and investigate children neurovascular disease. NIRS is particularly applicable to children as their thin scalp and skull allow improved review of structures within the brain. NIRS has become routine clinical practice in some areas of paediatric care. \nIn this pilot we will examine the feasibility and telerability of NIRS measurements of oxygenation and blood flow in children with moyamoya syndrome. Patients with moyamoya syndrome have inadequate blood supply to the brain and therefore reduced ability to regulate constant blood flow in (autoregulation). We hypothesise that in this patient group NIRS is able to detect this impaired autoregulation (the body’s ability to self-regulate), and therefore guide management strategies. However, before we can explore this hypothesis we need to establish that NIRS is feasible and well tolerated in the patient group.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference

    16/LO/2065

  • Date of REC Opinion

    29 Mar 2017

  • REC opinion

    Further Information Favourable Opinion